Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : January 5, 2016 4:37 PM IST
A novel drug target has been discovered by the Penn State scientists to rescue functional deficits in human nerve cells derived from patients with Rett Syndrome, a severe form of autism-spectrum disorder. According to lead researcher Gong Chen, the most exciting part of this research is that it directly uses human neurons which originated from Rett Syndrome patients as a clinically-relevant disease model to investigate the underlying mechanism. (Read: Early signs of autism and expert tips to deal with it)
Therefore, the new drug target discovered in this study might have direct clinical implication in the treatment of Rett Syndrome and potentially for other autism-spectrum disorders as well. The study has been published in the online Early Edition of the journal Proceedings of the National Academy of Sciences. (Read: Treating autism therapies and treatments)
Source: ANI
Photo source: Getty images
